Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Molecular Cancer Research : MCR|July 4, 2007
Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cellsChristopher F MacManus, Johanna Pettigrew, Angela Seaton, et al.
Molecular Cancer Therapeutics|June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cellsWendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
Oncotarget|May 7, 2016
Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancerPhilip D Dunne, Paul G O'Reilly, Helen G Coleman, et al.
Cancer Research|May 1, 2002
The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolatesDaniel B Longley, John Boyer, Wendy L Allen, et al.
Nature Reviews. Clinical Oncology|January 24, 2018
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2012
Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancerLeanne Stevenson, Wendy L Allen, Richard Turkington, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, et al.
The Journal of Pathology|December 3, 2003
Altered expression of the septin gene, SEPT9, in ovarian neoplasiaJames F Burrows, Severine Chanduloy, Michael A McIlhatton, et al.
Bioconjugate Chemistry|August 28, 2009
Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agentsCatherine A Higgins, Zoica Delbederi, Kelly McGarel, et al.
Molecular Cancer Therapeutics|March 19, 2008
Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formationCharlene K Mason, Suzanne McFarlane, Patrick G Johnston, et al.
Pageof 11